Investors are optimistic about Thermo Fisher's (TMO) better-than-expected results and robust international performance.
Investors remain optimistic about Patterson Companies (PDCO) on the back of its strong product line.
Cardinal Health's (CAH) fiscal fourth-quarter results benefit from a solid performance in the Pharmaceutical segment.